Uloric, illustration of tablet form (not a photo of the actual pack)

Illustrative image.

Uloric

Febuxostat

Prescription required

$255.00

80mg · 3 × 28 tablets · 3 months supply

BrandBranded medicine· By Patheon

$85.00 per month

How long a supply?

1 month$85.00 a month
3 months$85.00 a month
6 months$85.00 a month
Supplied from Israel

Test mode: no payment is taken. View cart

Annual cost

$1105a year at this pack size

Prescription required

Upload your prescription after ordering, or send it to our pharmacy team. We dispense only against a valid prescription.

80mg

FDA boxed warningCardiovascular death

Gout patients with established cardiovascular (CV) disease treated with ULORIC had a higher rate of CV death compared to those treated with allopurinol in a CV outcomes study.

Consider the risks and benefits of ULORIC when deciding to prescribe or continue patients on ULORIC. ULORIC should only be used in patients who have an inadequate response to a maximally titrated dose of allopurinol, who are intolerant to allopurinol, or for whom treatment with allopurinol is not advisable.

Read this with the rest of the clinical information

About Uloric

Overview

Uloric contains febuxostat and is used for the long-term management of high uric acid levels in adults with gout. It is intended for people whose uric acid levels are not adequately controlled with allopurinol, who cannot tolerate allopurinol, or for whom allopurinol is not advisable. It works by blocking an enzyme called xanthine oxidase, which lowers uric acid levels in the blood. Uloric is not recommended for high uric acid levels without symptoms.

What it treats

- Long-term management of high uric acid levels in adults with gout when allopurinol has not worked adequately despite dose adjustment, is not tolerated, or is not advisable. Not recommended for high uric acid levels without symptoms.

Safety information

Side effects

Common side effects include abnormal liver function tests, nausea, joint pain and rash. Gout flare-ups frequently increase when Uloric is first started. Serious risks include death from cardiovascular causes, liver failure, which can be fatal, and severe skin or allergic reactions, including Stevens–Johnson syndrome and toxic epidermal necrolysis. Contact a doctor promptly if liver injury or a serious skin or allergic reaction is suspected. Uloric should be stopped if a serious skin reaction is suspected, and treatment must be interrupted if liver injury is detected.

FDA boxed warning

Cardiovascular death

Gout patients with established cardiovascular (CV) disease treated with ULORIC had a higher rate of CV death compared to those treated with allopurinol in a CV outcomes study.

Consider the risks and benefits of ULORIC when deciding to prescribe or continue patients on ULORIC. ULORIC should only be used in patients who have an inadequate response to a maximally titrated dose of allopurinol, who are intolerant to allopurinol, or for whom treatment with allopurinol is not advisable.

A boxed warning is the strongest warning the US Food and Drug Administration requires on a medicine label. Text is taken from the official label, with internal section references removed.

When to call your doctor

• Seek medical attention immediately for a severe rash or a suspected serious skin or allergic reaction.

If symptoms are severe or getting worse quickly, seek emergency care rather than waiting.

Before taking this medicine

Do not take Uloric if you are being treated with azathioprine or mercaptopurine. Uloric requires caution in people with severe liver impairment because it has not been studied in this group. It is not recommended for people with secondary hyperuricemia, including those being treated for Lesch-Nyhan syndrome or cancer, or organ transplant recipients, because it has not been studied in these groups. Liver failure, including fatal cases, and serious skin or hypersensitivity reactions have been reported. Treatment should be interrupted promptly if liver injury is detected and stopped permanently if the injury is confirmed and no other cause is found. Stop Uloric if a serious skin reaction is suspected. Gout flares may increase when treatment starts. A flare alone does not mean Uloric needs to be stopped.

Interactions

Uloric (febuxostat) can increase blood levels of azathioprine or mercaptopurine, which may cause severe toxicity. Tell your doctor if you take either medicine before starting Uloric.

Using Uloric

Dosing

Dosing is set by your prescriber. Each health care professional may prescribe medication differently according to a patient's medical history and condition, so follow the directions on your prescription label and speak to your doctor or pharmacist before changing anything.

Storage

Store below 25°C in a dry place, in the original pack, away from direct light and moisture. Do not keep it in a bathroom. Keep all medicines out of the sight and reach of children.

Clinical information on this page is summarised from the US FDA label ULORIC (FEBUXOSTAT) TABLET [TAKEDA PHARMACEUTICALS AMERICA, INC.] (DailyMed, retrieved 19 September 2026).

Patient information and references

Official and supporting information to read alongside advice from your prescriber or pharmacist.

Reviews

No reviews yet. Mail Order Drugs opened recently, and we publish reviews only from verified customers of this site, so this space stays empty until real ones arrive.

  • Every prescription order is checked by a licensed pharmacist before dispensing.
  • Payment pages are encrypted and card details never reach our servers.
  • We ship internationally, with cold-chain packing where a medicine needs it.

Related medicines